Core Points - Zhonghong Medical (300981.SZ) closed at 14.21 yuan, with a decline of 2.07%, and a total market capitalization of 6.094 billion yuan, currently in a state of breaking issue [1] - The company was listed on the Shenzhen Stock Exchange's ChiNext board on April 27, 2021, with an initial public offering of 41.67 million shares at a price of 48.59 yuan per share [1] - The highest price recorded on the first day of trading was 159.80 yuan, marking the peak since its listing, followed by a downward trend in stock price [1] - The total funds raised from the IPO amounted to 2.025 billion yuan, with a net amount of 1.896 billion yuan, exceeding the originally planned fundraising by 1.317 billion yuan [1] - The initial fundraising plan was to raise 580 million yuan for the production of nitrile gloves and to supplement working capital [1] Financial Distribution - The total issuance costs for the IPO were 128 million yuan, with underwriting and sponsorship fees amounting to 107 million yuan [2] - For the 2022 fiscal year, the profit distribution plan included a cash dividend of 7.00 yuan per 10 shares (tax included) and a capital reserve transfer of 3 shares for every 10 shares, resulting in a total cash dividend of 210,004,200 yuan [2] - The total share capital increased by 90,001,800 shares following the 2022 distribution [2] - For the 2021 fiscal year, the profit distribution plan included a cash dividend of 30.00 yuan per 10 shares (tax included) and a capital reserve transfer of 8 shares for every 10 shares, leading to a total cash dividend of 500,010,000 yuan [2] - The total share capital increased by 133,336,000 shares after the 2021 distribution [2] Future Projections - The 2024 profit distribution plan, announced for June 20, 2025, proposes a cash dividend of 2.5 yuan per 10 shares (tax included) and a capital reserve transfer of 1 share for every 10 shares, totaling a cash dividend of 97,142,899.50 yuan [3] - The total share capital is projected to increase to 428,864,960 shares after the 2024 distribution [3]
中红医疗跌2.07% 2021年上市即巅峰超募13亿元